Rapid Diagnostics Forecast Report 2025 – Designed for Product & Growth Teams

 Unlock 30% off global market reports with code ONLINE30 — get insights on tariff changes, macro trends, and global economic shifts.

 
 What is the current market size of the rapid diagnostics industry, and what growth rate is it expected to achieve?
 The rapid diagnostics market size has grown rapidly in recent years. It will grow from $32.01 billion in 2024 to $36.08 billion in 2025 at a compound annual growth rate (CAGR) of 12.7%. The growth in the historic period can be attributed to increasing prevalence of infectious diseases, rising demand for point-of-care testing, rise in antimicrobial resistance, increasing awareness of early disease detection, and rising healthcare expenditure in emerging markets.
 
 The rapid diagnostics market size is expected to see rapid growth in the next few years. It will grow to $57.71 billion in 2029 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be attributed to growing adoption of personalized medicine, increasing integration of ai in diagnostics, rising demand for home-based testing kits, growing investments in healthcare infrastructure, and increasing focus on pandemic preparedness. Major trends in the forecast period include advancement in microfluidics technology, innovation in biosensor-based diagnostics, integration of smartphone apps with diagnostic tools, advancement in lab-on-a-chip systems, and innovation in multiplexed testing platforms.
 
 Download Your Free Sample PDF:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=24679&type=smp
 
 What are the major drivers contributing to the growth of the rapid diagnostics market?
 The increasing prevalence of infectious disease is expected to propel the growth of the rapid diagnostics market going forward. Infectious disease refers to illnesses caused by pathogenic microorganisms such as bacteria, viruses, parasites, or fungi, which can be spread directly or indirectly from one person to another. The rise in prevalence of infectious diseases is driven by increased global travel, which contribute to faster transmission and higher infection rates. Rapid diagnostics help infectious diseases by enabling quick and accurate identification of pathogens, allowing for timely treatment decisions, reduced transmission, and improved patient outcomes. For instance, in May 2025, according to the The World Health Organization (WHO), Switzerland-based specialized agency of the United Nations responsible for international public health, since mid-February 2025, global SARS-CoV-2 (the virus responsible for causing COVID-19, an infectious disease)activity has been on the rise, based on data from sentinel sites, with the test positivity rate reaching 11%, a level last observed in July 2024. Therefore, the increasing prevalence of infectious disease are driving the rapid diagnostics market.
 
 What are the major market segments driving the growth of the rapid diagnostics industry?
 The rapid diagnostics market covered in this report is segmented –
 
 1) By Product Type: Kits, Reagents, Instruments, Other Product Types
 2) By Platform: Immunoassays, Molecular Detection, Other Rapid Diagnostic Platforms
 3) By Application: Blood Glucose Testing, Infectious Disease Testing, Cardiometabolic Testing, Pregnancy and Fertility Testing, Fecal Occult Blood Testing, Coagulation Testing, Toxicology Testing
 4) By Distribution Channel: Hospital Pharmacies, Brick and Mortar, E-Commerce, Other Distribution Channels
 5) By End Use: Diagnostic Centers, Homecare Settings, Hospital Pharmacies, Other End Users
 
 Subsegments:
 1) By Kits: Lateral Flow Assay Kits, PCR Kits, Immunoassay Kits, Microfluidic Kits, Molecular Diagnostic Kits, Multiplex Kits
 2) By Reagents: Enzymes, Buffers, Probes and Primers, Stains and Dyes, Antibodies, Calibration and Control Reagents
 3) By Instruments: PCR Machines, Lateral Flow Readers, Immunoassay Analyzers, Microfluidic Analyzers, Automated Sample Processors, Biosensors
 4) By Other Product Types: Software and Data Management Tools, Sample Collection Devices, Accessories and Consumables, Calibration Standards, Point-of-Care Devices
 
 View The Full Market Report:
 https://www.thebusinessresearchcompany.com/report/rapid-diagnostics-global-market-report
 
 How are emerging trends transforming the rapid diagnostics market dynamics?
 Major companies operating in the rapid diagnostics market are focusing on advancements and innovation, such as rapid diagnostic testing tools, to enhance diagnostic accuracy, reduce turnaround times, and improve patient outcomes in point-of-care settings. Rapid diagnostic testing tools refer to medical devices that quickly detect the presence of specific diseases or conditions, typically providing results within minutes at the point of care. For instance, in May 2025, SEKISUI Diagnostics a US-based medical diagnostics manufacturer, launched the OSOM RSV Test, a rapid diagnostic tool for detecting respiratory syncytial virus (RSV). This test is intended for use in professional healthcare settings and delivers results in just 15 minutes. It employs a rapid immunochromatographic assay to qualitatively detect RSV nucleoprotein antigen. The test uses anterior nasal swab specimens collected from patients showing symptoms of respiratory infection. Its quick turnaround time supports timely and effective clinical decision-making.
 
 Who are the key market players contributing to the growth of the rapid diagnostics industry?
 Major companies operating in the rapid diagnostics market are Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Quest Diagnostics Incorporated, Hologic Inc., bioMérieux S.A., QuidelOrtho Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Cepheid Inc., OraSure Technologies Inc., Nova Biomedical Corporation, Fujirebio Holdings Inc., Sekisui Diagnostics LLC, EKF Diagnostics Holdings plc, Trinity Biotech plc, Abingdon Health plc, Abionic SA
 
 Which regions are leading the growth of the rapid diagnostics market globally?
 North America was the largest region in the rapid diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rapid diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
 
 How Can Companies Use The Rapid Diagnostics Market Report to Drive Business Results?
 This report provides actionable insights tailored for business use — not academic analysis. Companies can leverage the data to:
 • Time market entry or expansion using growth forecasts and CAGR trends.
 • Develop competitive products by tracking key technology shifts and user preferences.
 • Tailor regional strategies with in-depth geographic data and local market dynamics.
 • Benchmark and plan partnerships using competitive landscape insights.
 
 Purchase The Report And Get A Swift Delivery:
 https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24679
 
 Need Customized Data On Rapid Diagnostics Market?
 For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
 
 Request Customized Data:
 https://www.thebusinessresearchcompany.com/customise?id=24679&type=smp
 
 About The Business Research Company:
 
 With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
 
 Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
 
 Contact Us:
 
 The Business Research Company
 
 https://thebusinessresearchcompany.com/
 
 Americas +1 310–496-7795
 Asia +44 2071930708
 Europe +44 7882 955267
 Email us at info@tbrc.info
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company